Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy
Abstract Background While many studies of effective hereditary angioedema (HAE) therapy have demonstrated improved health-related quality of life (HRQoL) using validated instruments, specific reasons behind the improved scores have never been investigated using qualitative methods. A non-interventio...
Main Authors: | John Anderson, Donald S. Levy, William Lumry, Patricia Koochaki, Sally Lanar, H. Henry Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-021-00550-5 |
Similar Items
-
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
by: Donald S. Levy, et al.
Published: (2020-02-01) -
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study
by: H. Henry Li, et al.
Published: (2019-08-01) -
Hereditary angioedema
by: Helen Lesser, et al.
Published: (2021-07-01) -
Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
by: William Raymond Lumry
Published: (2018-02-01) -
Prevalence of autoantibodies in a group of hereditary angioedema patients Prevalência de autoanticorpos em uma população com angioedema hereditário
by: Sergio Duarte Dortas Junior, et al.
Published: (2012-04-01)